Your private tour of the Crohn’s & Colitis Congress Poster Hall

Contribute
Published on By
Leave a comment991 views

The inaugural Crohn’s & Colitis Congress™ (Jan. 18-20, 2018, Las Vegas, Nevada) gathered more than 1,250 inflammatory bowel disease (IBD) health care professionals and featured more than 250 abstracts — with the goal of advancing research and transforming the care of IBD patients.

The Crohn’s & Colitis Congress is a new partnership between the Crohn’s & Colitis Foundation and AGA. Both organizations are proud of the success of the inaugural meeting and would like to thank all faculty and attendees. If you are involved in the research or care of IBD patients, save the date for the 2019 meeting: Feb. 7-9 in Las Vegas.

Here’s a glimpse of the science presented at the meeting. Edward V. Loftus Jr., MD, AGAF, an IBD expert and presenter at the Congress, took over AGA’s Twitter handle during the meeting to take us on a tour of the poster hall, selecting six noteworthy studies to share. You can review all abstracts presented at the Crohn’s & Colitis Congress in AGA’s journal Gastroenterology.

Serum Albumin Week 6/Week 0 Ratio After Anti-TNF Best Predicts Both Short- and Long-Term Clinical Outcomes in Anti-TNF-Naïve Ulcerative Colitis Patients

Vedolizumab Trough Levels and Antibodies in Inflammatory Bowel Disease: Updated Initial Experience

Impact of Obesity on Future IBD-Related Complications in a Population-Based Cohort of Crohn’s Disease and Ulcerative Colitis Patients

Obesity and Response to Infliximab in Patients with Inflammatory Bowel Diseases: Pooled Analysis of Individual Participant Data from Clinical Trials

Opioid Dependence is on the Rise Among IBD Hospitalizations

A Diet Low in Red and Processed Meats Does Not Reduce the Rate of Crohn’s Disease Flares in a Randomized Controlled Trial: Results of the Food and Crohn’s Disease Exacerbation Study (FACES)

Join the discussion

Your email address will not be published. Required fields are marked *